Unraveling the Long-Standing Mystery of Nicotine Production
For centuries, scientists have marveled at tobacco plants' ability to produce nicotine, a potent alkaloid that serves as both a defense mechanism against herbivores and the source of human addiction. Discovered in 1828, nicotine's role in plant biology has been partially understood, but the final steps of its biosynthesis remained elusive despite decades of research. This gap hindered advances in plant metabolic engineering and synthetic biology. In a landmark achievement published in the journal Cell on April 10, 2026, a team of Chinese researchers led by Prof. Dapeng Li from the Center for Excellence in Molecular Plant Sciences (CEMPS) at the Chinese Academy of Sciences (CAS) has finally mapped the complete pathway in the wild tobacco species Nicotiana attenuata.
The discovery reveals a sophisticated five-enzyme metabolon—a transient protein complex—that orchestrates the precise assembly of nicotine at the vacuolar membrane. This breakthrough not only resolves a 200-year-old puzzle but also opens doors to engineering pest-resistant crops and producing high-value alkaloids sustainably.
Background: Nicotine's Dual Role in Plants and Human Society
Nicotine (C10H14N2), chemically a pyridine-pyrrolidine alkaloid, is primarily synthesized in the roots of tobacco plants (Nicotiana tabacum and relatives) and translocated to leaves. In nature, it acts as an insecticide, deterring pests like the tobacco hornworm. Concentrations can reach 3-5% dry weight in commercial tobacco, making it economically vital for the $800 billion global tobacco industry, though it poses health risks leading to 8 million annual deaths from smoking-related diseases, per World Health Organization data.
Understanding biosynthesis is crucial for reducing nicotine in commercial varieties (to curb addiction) or enhancing it in biofactories for pesticides and pharmaceuticals. Prior knowledge covered the pyrrolidine ring from ornithine via putrescine N-methyltransferase (PMT) and N-methylputrescine oxidase (MPO), yielding N-methyl-Δ1-pyrrolinium (MP), and the pyridine ring from aspartate to nicotinic acid (NA) via quinolinate pathway enzymes. The coupling of MP and NA via a Mannich-like reaction was hypothesized but unproven.
The Research Team and Their Innovative Approach
Prof. Li Dapeng's group at CAS's Shanghai Institute of Plant Physiology and Ecology, in collaboration with the Max Planck Institute for Chemical Ecology in Germany, employed a multi-omics strategy. They constructed a co-association network integrating genomics, transcriptomics, and untargeted metabolomics across population, individual, and single-cell levels, guided by information theory.
Key innovation: screening 643 mutant lines from ethyl methanesulfonate-mutagenized N. attenuata seeds, identifying the nicotine-free 'ao2' mutant. Map-based cloning pinpointed the causal gene, NaUGT1, a UDP-glycosyltransferase. Virus-induced gene silencing (VIGS) and CRISPR validated roles of other enzymes.
"This discovery completes the decades-old puzzle of nicotine biosynthesis," Prof. Li stated, highlighting its paradigm-shifting potential for alkaloid engineering.
Key Enzymes and the Dynamic Metabolon
The final steps involve a five-component metabolon assembling transiently at the tonoplast (vacuolar membrane):
- NaUGT1 (UDP-glycosyltransferase): Glycosylates NA to nicotinic acid-N-glucoside (NAG), stabilizing the reactive substrate.
- NaA622 (reductase): Reduces NAG, triggers decarboxylation, and activates for condensation.
- NaBBL1/NaBBL2 (berberine bridge enzyme-like): Catalyzes stereoselective intermolecular Mannich-like reaction with MP, oxidizing to favor (S)-nicotine.
- NaBGL1/NaBGL2 (β-glucosidases): Deglycosylate nicotine-N-glucoside (NG) to free nicotine.
- NaMATE1 (MATE transporter): Pumps nicotine into vacuoles, preventing cytoplasmic toxicity.
Protein interactions (BiFC, FRET, pull-down) confirmed the metabolon's formation, enabling substrate channeling—intermediates don't accumulate freely, boosting efficiency 10-fold.
Photo by Google DeepMind on Unsplash
| Enzyme | Role | Location |
|---|---|---|
| NaUGT1 | Glycosylation of NA | Tonoplast |
| NaA622 | Reduction/activation | Tonoplast |
| NaBBL1/2 | Oxidation/condensation | Tonoplast |
| NaBGL1/2 | Deglycosylation | Tonoplast |
| NaMATE1 | Transport to vacuole | Tonoplast |
Step-by-Step Mechanism of Nicotine Assembly
- Pyridine precursor supply: NaNAMNH hydrolyzes NAMN to NA (NAD-independent).
- Glycosylation: NaUGT1 adds glucose to NA → NAG (stabilizes).
- Reduction and activation: NaA622 reduces NAG → dihydropyridine-N-glucoside + CO2.
- Mannich-like condensation: Dihydropyridine attacks MP (stereoselectively, NaBBL aids).
- Oxidation: NaBBL1/2 oxidizes intermediate → NG.
- Deglycosylation: NaBGL1/2 → nicotine.
- Sequestration: NaMATE1 transports to vacuole.
Chiral LC-MS confirmed (S)-nicotine exclusivity. Wound/jasmonate induction synchronizes expression.
Experimental Validation and Reconstitution
VIGS/CRISPR knockouts depleted nicotine >90%. Heterologous expression in yeast produced 1.2 mg/L nicotine; in N. benthamiana, 0.5% leaf dry weight. Engineered tomato/eggplant/pea gained pest resistance—Spodoptera litura larvae mortality 70% higher.
In vitro assays confirmed sequential catalysis; AlphaFold predicted interactions matching experiments.
Agricultural and Economic Implications
Tobacco supports 50 million farmers globally. Low-nicotine mutants aid 'reduced-risk' products; high-nicotine crops could replace synthetic pesticides (nicotine used since 1690). Engineering non-tobacco Solanaceae (potato, tomato) for defense reduces chemical use, aligning with sustainable agriculture goals.
In China, tobacco yields 2.5 million tons annually; pathway knowledge optimizes varieties amid climate stress.
Pharmaceutical and Synthetic Biology Frontiers
Nicotine analogs target neurology (Alzheimer's, Parkinson's). Metabolon engineering scales alkaloids like morphine, vinblastine. The glycosylation strategy applies to 20% plant natural products.
Read the full Cell paper for protocols.
Photo by National Cancer Institute on Unsplash
China's Growing Prowess in Plant Sciences
CAS institutes lead globally; 2025 Nature Index ranks China #1 in plant biology. CEMPS focuses on trait design, with 500+ papers yearly. Collaborations like CEPAMS (CAS-JIC) accelerate discoveries.
This work exemplifies China's 15th Five-Year Plan emphasis on biotech self-reliance.
Future Directions and Challenges
Challenges: scaling metabolons in crops, regulatory hurdles for GM plants. Outlook: AI-omics for alkaloid mining, climate-resilient varieties. Global impact: safer pesticides, novel therapeutics.
Prof. Li's team plans heterologous platforms for commercial nicotine-free tobacco and alkaloid factories.
